The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
803
October 20, 1989
View Complete Issue         Table of Contents 2019 
Ovral As A 'Morning-After' Contraceptive
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Ovral As A 'Morning-After' Contraceptive
October 20, 1989 (Issue: 803)
High doses of various hormones have been used for many years to prevent pregnancy after unprotected coitus. Diethylstilbestrol (DES), a synthetic estrogen, was once approved for this purpose by the US Food and Drug Administration (Medical Letter...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Ovral As A 'Morning-After' Contraceptive
Article code: 803a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.